I expected my four-day essay experiment to answer a fairly simple question: could an essay writing service handle a complicated systems-analysis assignment without turning it into a collection of disconnected facts? I chose a difficult topic on purpose. The assignment required a systems map of shortages of essential injectable medicines, an explanation of feedback loops, an analysis of low margins and concentrated production, a disturbance traced through several parts of the system, and an evaluation of an intervention. It also required 1,300–1,600 words, APA 7th Edition, and at least seven credible sources, including three published since 2022.

That mattered because this was not an assignment where subjects that encourage thoughtful debate could be handled with a generic five-paragraph structure. The paper needed research, organization, causal reasoning, and some restraint. After four days of working through the process, my main finding was that the service was much more useful as a structured research and writing resource than I initially expected, but the complexity of the assignment still made my own review essential.

I deliberately treated the experience as a test rather than simply ordering a paper and accepting whatever arrived. I wanted to see how the process handled a demanding brief, how communication worked, whether the final paper actually followed the specifications, and where I still needed to intervene.

Why I picked such an awkward assignment

I could have tested the service with a conventional argumentative essay. That would have made the experiment easier, but it would not have told me much. A systems-analysis paper creates several opportunities for mistakes because the writer has to connect evidence rather than merely summarize it.

The subject also had enough current research behind it to make source quality measurable. The FDA identifies manufacturing quality problems as a major cause of drug shortages and notes that older sterile injectable drugs can be particularly vulnerable because relatively few manufacturers and raw-material suppliers may serve the market.

I wanted the assignment to force those relationships onto the page.

The exact requirements gave me a useful control condition. The writer had to produce between 1,300 and 1,600 words, use APA 7, include at least seven academic, government, technical, or industry sources, and include at least three sources published since 2022. More importantly, the paper could not simply say that shortages happen because "the supply chain is complicated." It had to explain how one event could move through manufacturers, suppliers, wholesalers, hospitals, and regulators.

That gave me several things I could check after delivery.

Day 1: Setting up the test

The first day was mostly about making the assignment difficult enough to be meaningful without adding artificial obstacles.

I submitted the full prompt rather than reducing it to a short description. I wanted to see whether the service could preserve the unusual requirements, especially the request for both a reinforcing feedback loop and a balancing mechanism.

I also specified the word range and citation style exactly. I did not provide my own sources or a proposed argument. If I had already done the intellectual work, the experiment would have measured editing more than writing.

One thing I noticed during the ordering process was that EssayPay uses a managed writer-matching model. For a first order, the platform matches the assignment with a writer according to the topic, academic level, and deadline rather than asking me to browse a long list of writers. The order form also asks for the paper type, subject, academic level, page count, deadline, instructions, and attachments.

That made sense for this particular experiment because the assignment was specialized enough that I cared more about subject fit than about choosing a writer based on a profile.

The price and deadline were displayed before payment, which also gave me a clear starting point for the test. I chose a four-day turnaround rather than an emergency deadline. I wanted enough time for research and writing, but not so much time that the assignment could be treated as an open-ended project.

Day 2: I started thinking about the system differently

The second day was when I realized why this assignment was a better test than a normal essay.

Before the paper existed, I tried to sketch the causal structure myself. The basic chain looked something like this:

Low prices and limited expected returns → fewer incentives for redundant capacity → concentrated manufacturing → greater exposure to a single production failure → reduced supply → hospital purchasing pressure and substitutions → additional pressure on remaining suppliers.

But that was only one direction. A systems map needs feedback, not a straight line.

A reinforcing loop could begin with low profitability. If manufacturers earn relatively little from an injectable product, investment in redundant facilities may become harder to justify. Fewer manufacturers or facilities then means that a disruption affects a larger share of available supply. A shortage can increase pressure on the remaining producers, but it does not necessarily create an immediate incentive or ability to add capacity because sterile manufacturing requires specialized facilities, validation, and regulatory compliance.

That relationship is supported by recent economic and government analysis. A 2024 HHS analysis found that 70% of recently launched generic injectable drugs did not reach profitability by their third year under the study's estimates, while the market also had fewer manufacturers per molecule than the generic oral market.

The GAO reached a related conclusion from a broader policy perspective. Its 2025 report noted that sterile injectables made up 71 of 102 drugs in active shortage as of July 31, 2024, and cited low prices, low profit margins, manufacturing complexity, and market structure as factors associated with their vulnerability.

The paper therefore needed to explain something more subtle than "companies want profits." The interesting question was how reasonable decisions by individual organizations could combine into a fragile system.

Day 3: The research was where I became picky

The next day I focused less on the prose and more on the evidence.

This was important because a paper can look scholarly while relying on weak sources. I wanted government reports and recent research to carry the central claims rather than random websites discussing shortages.

One of the most useful sources was the FDA's 2023 pharmaceutical-quality report. It identifies quality problems and manufacturing delays among the major reasons for new shortages and discusses how consolidation among active pharmaceutical ingredient suppliers can increase vulnerability when multiple finished-dose manufacturers depend on a small number of sources.

I also used the FDA's 2024 annual report, which describes efforts to encourage more mature quality-management practices and improve coordination around manufacturing quality.

A 2024 policy analysis from HHS was particularly useful for the systems perspective because it describes shortages as a problem crossing manufacturers, middlemen, providers, and pharmacies. It also identifies low generic prices and concentration among intermediaries as factors that can weaken incentives for redundancy and resilience.

The evidence started making the assignment feel less abstract.

I could now trace a plausible disturbance.

Imagine a quality problem forces a major injectable manufacturing line to stop production. The first effect is straightforward: output falls. The second effect is less obvious. Hospitals still need the medicine, so distributors and purchasing organizations look for alternative supply. If other manufacturers are already operating close to capacity, they cannot instantly replace the missing volume. FDA guidance specifically notes that sterile injectable production can be vulnerable because of limited manufacturers, constrained raw-material capacity, long lead times, and manufacturing complexity.

Then the disturbance changes form again. Hospitals may switch products, alter protocols, conserve inventory, or ask pharmacists to locate alternatives. The shortage is no longer just a factory problem. It has become a coordination problem.

That was the kind of connection I wanted the finished paper to make.

Day 4: What I received and how I evaluated it

By the fourth day, I was less interested in whether the paper "sounded good" and more interested in whether it passed the original test.

The first thing I checked was length. The paper stayed within the required range. I then checked the reference list against the body of the paper rather than assuming that a long bibliography meant the sources had actually been used.

The systems map was also important. I wanted to see an actual relationship between variables, not a decorative diagram inserted because the prompt demanded one.

The strongest part of the paper, in my view, was the explanation of the quality-shock scenario. It connected a manufacturing shutdown to reduced supply, constrained alternative capacity, distributor and hospital responses, and regulatory involvement. That sequence made the shortage understandable as a system rather than a single company's failure.

The weaker part was the intervention analysis.

The paper proposed strengthening incentives for manufacturers to invest in quality and resilient capacity. That is a reasonable leverage point, and the FDA has been developing quality-management approaches intended to support a more reliable supply chain. But the intervention needed a clearer second-order consequence.

For example, encouraging manufacturers to maintain more redundant capacity could improve resilience, but it could also raise production costs. If purchasing contracts continue to reward the lowest short-term price, manufacturers may struggle to recover those costs. In other words, improving one part of the system without changing the purchasing incentives could produce a smaller effect than expected.

That was the point where I realized the assignment was difficult for a reason: there was no single lever that solved everything.

The feedback loop that made the most sense

The reinforcing loop I ultimately found most convincing was the interaction between profitability, concentration, and vulnerability.

Lower expected returns can contribute to market exit or discourage investment. Fewer producers mean greater concentration. Greater concentration means a disruption at one facility represents a larger portion of available capacity. The resulting shortage creates pressure on the remaining producers, but specialized sterile production cannot necessarily expand quickly.

Research published before this experiment had already identified the relationship between manufacturing quality problems and shortages, including evidence that failures at individual establishments can have wider consequences when alternative capacity is limited.

The balancing mechanism was different. Regulatory oversight, early notification, quality improvements, and alternative sourcing can push against the reinforcing loop. The FDA explains that advance notice of supply problems can allow the agency to act earlier, while its shortage-management system is designed to work with manufacturers to mitigate disruptions.

Neither mechanism is magic. That distinction mattered in the final paper.

What surprised me about the four days

I expected the biggest problem to be writing quality. It wasn't.

The more difficult issue was whether the argument actually reflected the evidence. A fluent paragraph can hide a weak causal connection surprisingly well.

I also underestimated how important source dates would become. The assignment required three sources from 2022 onward, but recent sources were not automatically better for every claim. Older GAO research still helped explain the economics of generic sterile injectables, while newer HHS, FDA, and GAO material helped establish the current policy and market context.

Another useful observation was that shortages do not always mean a medicine has disappeared everywhere. FDA distinguishes national shortages from local supply problems, which can sometimes be temporary distribution issues. That distinction helped me tighten several statements in my review.

What I would do differently next time

If I repeated the experiment, I would spend more time before ordering on defining what I consider a successful argument.

I would probably provide one sentence clarifying that every causal claim needs to be tied either to a source or to an explicitly labeled analytical inference. I would also ask for the system map to be treated as part of the argument rather than as a separate illustration.

I would not, however, provide a complete outline. That would defeat part of the purpose of testing the service.

I would also leave enough time for my own review. EssayPay provides direct communication with the assigned writer and allows revisions after delivery, with free revisions available under its stated order terms. For a complex assignment, I would use that opportunity if a causal relationship, citation, or formatting detail did not match the original instructions.

Most importantly, I would treat the delivered paper as a working academic resource rather than something I could submit without reading. The service itself describes delivered papers as model or reference materials and places responsibility for compliance with institutional academic-integrity rules on the student.

What the experiment actually taught me

Four days was enough to expose the difference between having words on a page and having a defensible argument.

The essay-writing process worked best when I judged it against the assignment's actual requirements: a defined system, identifiable actors, feedback relationships, a traced disturbance, a specific intervention, a second-order effect, recent evidence, and correct formatting.

The larger lesson came from the subject itself. Drug shortages are not produced by one careless decision. A manufacturer can make a rational cost decision, a hospital can try to protect patients, a wholesaler can manage inventory, and a regulator can enforce quality requirements, yet the combined system can still become fragile. Recent U.S. evidence continues to show how strongly sterile injectables feature in shortage data and how manufacturing, market structure, and quality problems interact.

That is also what I learned from the four-day test. I would not treat one order as proof that every assignment will receive the same treatment. What I can say is that this particular experiment gave me a useful way to judge an essay-writing service: don't start with whether the prose sounds impressive. Start with whether the writer understood the assignment, built the required reasoning, used appropriate evidence, and gave me enough time and information to verify the result myself.

For a complicated research paper, that distinction matters more than polished sentences.

You Might Also Like

Which essay writing service do Reddit users recommend most?

Understanding Academic vs. Casual English in Essay Writing

How Gaming Helps Every Student Build Strategic Thinking Skills

EssayPay: Why Students Trust This Essay Writing Service